- Home
- TLSI vs MED Comparison
TLSI vs MED Comparison
Compare TLSI & MED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- MED
- Stock Information
- Founded
- TLSI 2010
- MED 1980
- Country
- TLSI United States
- MED United States
- Employees
- TLSI N/A
- MED N/A
- Industry
- TLSI Medical Specialities
- MED Packaged Foods
- Sector
- TLSI Health Care
- MED Consumer Staples
- Exchange
- TLSI Nasdaq
- MED Nasdaq
- Market Cap
- TLSI 158.0M
- MED 187.3M
- IPO Year
- TLSI N/A
- MED N/A
- Fundamental
- Price
- TLSI $5.77
- MED $14.73
- Analyst Decision
- TLSI Strong Buy
- MED Hold
- Analyst Count
- TLSI 6
- MED 1
- Target Price
- TLSI $11.75
- MED $16.50
- AVG Volume (30 Days)
- TLSI 40.4K
- MED 230.8K
- Earning Date
- TLSI 03-27-2025
- MED 02-18-2025
- Dividend Yield
- TLSI N/A
- MED N/A
- EPS Growth
- TLSI N/A
- MED N/A
- EPS
- TLSI N/A
- MED 0.19
- Revenue
- TLSI $26,891,000.00
- MED $602,463,000.00
- Revenue This Year
- TLSI $61.29
- MED N/A
- Revenue Next Year
- TLSI $53.21
- MED N/A
- P/E Ratio
- TLSI N/A
- MED $77.53
- Revenue Growth
- TLSI 67.90
- MED N/A
- 52 Week Low
- TLSI $3.50
- MED $13.57
- 52 Week High
- TLSI $10.42
- MED $42.68
- Technical
- Relative Strength Index (RSI)
- TLSI 68.94
- MED 39.93
- Support Level
- TLSI $5.40
- MED $13.57
- Resistance Level
- TLSI $5.82
- MED $16.66
- Average True Range (ATR)
- TLSI 0.24
- MED 0.74
- MACD
- TLSI 0.01
- MED -0.02
- Stochastic Oscillator
- TLSI 89.19
- MED 37.54
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About MED MEDIFAST INC
Medifast Inc is a United states based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.